AXSM Competitors & Alternatives
Compare Axsome Therapeutics Inc with similar stocks in the same industry
Biotechnology
AXSM
Main Stock$237.92
Tradestie Score
59
Market Cap
$5.92B
Revenue Growth
0.6%
Analyst Upside
+16.2%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.25
|
$15.22B | - | 48 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.01
|
$12.36B | 27.4 | 55 | Compare |
|
EXEL
Exelixis Inc
|
$52.87
|
$11.09B | 17.0 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.01
|
$10.76B | - | 65 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$60.42
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.33
|
$10.53B | 40.6 | 66 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$76.52
|
$10.49B | - | 61 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$69.36
|
$10.22B | - | 67 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$509.76
|
$10.01B | - | 60 | Compare |
|
TECH
Bio-Techne Corp.
|
$58.88
|
$9.33B | 80.4 | 56 | Compare |
More AXSM Analysis
Data updated: Jun 25, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry